CIBMTR Reporting Implementation Guide
0.1.9 - Trial Use 1

This page is part of the CIBMTR Reporting Implementation Guide (v0.1.9: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example Medication: Medication-Post-HCT-Disease-Therapy-Example

Profile: CIBMTR Planned Post-HCT Disease Therapy Medication

Security Label: 99999 My Transplant Center (Details: transplant-center code rc_99999 = '99999 My Transplant Center')

code: blinatumomab

Ingredients

-Item[x]Strength
*blinatumomab0.035 milligram (Details: UCUM codemg = 'mg')/0.035 milligram (Details: UCUM codemg = 'mg')